ArticleJournal for immunotherapy of cancer2021

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.

Jenny Sprooten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.